Ignite Creation Date:
2025-12-24 @ 10:54 PM
Ignite Modification Date:
2026-03-20 @ 8:07 PM
Study NCT ID:
NCT01522469
Status:
COMPLETED
Last Update Posted:
2024-01-30
First Post:
2012-01-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study of Crenolanib in Subjects With Relapsed/Refractory AML With FLT3 Activating Mutations
Sponsor:
Organization: